YOLFTbeta
Tibet Cheezheng Tibetan Medicine Co Ltd

Tibet Cheezheng Tibetan Medicine Co Ltd

002287 · SHE · Healthcare / Biotechnology

18.53CNY-0.29 (-1.54%)

Price History

Full chart

Market Stats

Previous Close18.82
Open18.82
Day Range18.48 – 18.86
52-Week Range18.12 – 26.47
Volume2.03M
Market Cap11.09B
P/E (TTM)16.71
Forward P/E30.40
EPS1.16
Dividend Yield3.35%
Beta0.14
50-Day Avg20.17
200-Day Avg22.16

About

Tibet Cheezheng Tibetan Medicine Co., Ltd. engages in the research, development, production, and sale of Tibetan medicines in China and internationally. The company also provides plasters, topical and oral Tibetan and traditional Chinese medicine products, external analgesics, and ointments. Its products are used in areas of orthopedics, neurology, dermatology, granules, gynecology, pediatrics, respiratory, gastroenterology, cardiovascular, musculoskeletal system, nervous system, respiratory, digestive, urinary, and cerebrovascular sectors. The company was founded in 1995 and is headquartered in Nyingchi, China. Tibet Cheezheng Tibetan Medicine Co., Ltd. is a subsidiary of Gansu Qizheng Industry Group Co., Ltd.

Company Details

  • SectorHealthcare
  • IndustryBiotechnology
  • CEOMr. Haijian Xia
  • Employees3.20K
  • HeadquartersNo. 2, Deji Road, Nyingchi, China, 860000, China
  • Websitehttps://www.cheezheng.com.cn

Leadership

  • Mr. Haijian XiaPresident & Director · b. 1975
  • Ms. Guilan LuChief Financial Officer · b. 1972
  • Mr. Weiwu ChenChief Scientific Officer · b. 1972
  • Ms. Jianqin XiaoExecutive Vice President · b. 1969
  • Mr. Jun LiSenior Vice President · b. 1975
  • Ms. Ping FengSenior VP & Secretary of the Board of Directors · b. 1970
  • Mr. Tenzin WanmaDirector of Cultural Heritage · b. 1981
  • Ms. Min ZhaoVice President · b. 1972
  • Mr. Tianzhe LiVice President · b. 1975
  • Ai Ping ZhangAccounting Supervisor

Financials

Income Statement

Currency: CNY2006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue267.92M339.27M413.48M469.30M523.65M789.23M934.27M969.47M950.11M994.73M968.35M1.05B1.21B1.40B1.49B1.77B2.04B2.05B2.34B2.42B
Growth (%)-+26.63%+21.87%+13.50%+11.58%+50.72%+18.38%+3.77%-2.00%+4.70%-2.65%+8.76%+15.20%+15.62%+5.87%+19.22%+15.49%+0.02%+14.32%+3.34%
Cost of Revenue56.75M63.28M70.63M97.25M135.93M359.25M439.49M366.08M258.07M204.01M150.46M134.01M150.62M182.11M217.36M269.70M325.52M324.70M419.55M409.47M
Gross Profit211.17M275.99M342.85M372.05M387.72M420.93M494.78M603.39M692.03M790.72M817.89M919.14M1.06B1.22B1.27B1.50B1.72B1.72B1.92B2.42B
Gross Margin78.82%81.35%82.92%79.28%74.04%53.34%52.96%62.24%72.84%79.49%84.46%87.28%87.59%87.02%85.36%84.77%84.08%84.12%82.05%100.00%
Operating Expense113.89M166.92M209.41M232.23M244.15M236.82M298.45M394.81M459.12M517.63M542.45M597.21M708.54M819.04M812.09M710.58M1.20B1.07B1.26B1.65B
Operating Income97.28M109.08M133.44M139.82M143.56M184.11M196.33M208.58M232.91M273.09M275.43M321.93M354.05M401.53M455.61M790.21M521.54M646.38M657.03M762.95M
Operating Margin36.31%32.15%32.27%29.79%27.42%23.33%21.01%21.51%24.51%27.45%28.44%30.57%29.18%28.63%30.68%44.63%25.51%31.61%28.10%31.58%
EBITDA94.72M127.86M147.22M173.05M182.77M196.40M238.57M282.10M311.47M325.36M347.41M351.16M373.48M442.26M511.78M904.36M652.05M796.64M814.60M842.16M
EBITDA Margin35.35%37.69%35.60%36.87%34.90%24.89%25.54%29.10%32.78%32.71%35.88%33.34%30.78%31.53%34.46%51.08%31.89%38.95%34.84%34.86%
Net Income105.95M115.84M135.80M160.81M170.46M170.72M190.18M213.37M237.53M264.91M289.86M300.84M318.77M364.25M403.96M715.88M472.54M581.20M582.28M646.23M
Net Income Margin39.55%34.14%32.84%34.27%32.55%21.63%20.36%22.01%25.00%26.63%29.93%28.57%26.27%25.97%27.20%40.43%23.11%28.42%24.91%26.75%
R&D------33.49M37.92M39.13M40.39M42.78M41.87M36.81M55.55M60.32M70.82M47.46M50.54M60.40M81.03M
R&D as % of Total Revenue------3.58%3.91%4.12%4.06%4.42%3.98%3.03%3.96%4.06%4.00%2.32%2.47%2.58%3.35%
Interest Expense-336.60K214.20K081.10K144.39K129.29K180.10K0745.23K3.24M4.09M9.46M4.97M23.03M56.12M56.42M66.79M60.36M41.86M
Interest Expense % of Total Revenue-0.10%0.05%0.00%0.02%0.02%0.01%0.02%0.00%0.07%0.33%0.39%0.78%0.35%1.55%3.17%2.76%3.27%2.58%1.73%

Balance Sheet

Currency: CNY2006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets590.98M514.70M631.30M1.30B1.32B1.36B1.43B1.53B1.79B2.07B2.08B2.30B2.31B2.98B4.46B5.57B5.89B6.30B6.79B6.92B
Total Liabilities134.37M118.37M99.02M152.68M110.72M80.01M80.90M86.34M242.20M419.05M324.33M402.78M267.54M722.20M1.82B2.35B2.50B2.53B2.68B1.92B
Total Equity454.91M395.29M531.08M1.14B1.19B1.24B1.32B1.41B1.50B1.61B1.73B1.88B2.03B2.25B2.62B3.17B3.34B3.72B4.06B4.95B
Cash307.32M174.81M214.95M826.97M761.11M521.13M515.47M524.99M283.87M352.44M457.93M386.43M395.51M1.35B1.83B666.63M437.57M403.43M189.59M376.44M
Total Debt-5.00M3.21M------130.00M116.50M220.00M-300.19M1.21B1.45B1.70B1.52B1.61B-
Net Debt-307.32M-169.81M-211.73M-826.97M-761.11M-521.13M-515.47M-524.99M-283.87M-222.44M-341.43M-166.43M-395.51M-1.05B-622.21M785.59M1.26B1.12B1.42B542.55M

Cash Flow

Currency: CNY2006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow38.50M91.43M65.93M175.58M96.91M-11.74M169.67M198.48M310.95M257.81M389.20M229.83M499.40M405.95M238.65M1.03B285.69M693.41M456.75M729.70M
Investing Cash Flow-58.13M-21.77M-23.79M-16.44M-56.83M-125.81M-61.65M-74.36M-418.06M-161.31M-101.27M-242.71M-95.52M377.85M-592.25M-2.16B-334.50M-310.59M-518.02M-
Financing Cash Flow--206.56M-2.00M452.88M-105.93M-102.43M-113.68M-114.61M-134.00M-78.85M-238.65M-83.80M-262.49M166.20M839.01M-42.76M-183.22M-431.90M-138.21M-
Capital Expenditure13.91M30.49M23.79M16.44M57.32M86.99M61.65M74.38M81.48M64.90M179.87M66.13M128.94M52.27M338.97M125.57M272.40M234.81M255.44M153.08M
Free Cash Flow24.59M60.95M42.13M159.14M39.58M-98.73M108.02M124.10M229.47M192.91M209.33M163.70M370.45M353.68M-100.32M909.35M13.29M458.59M201.31M576.63M
Dividends Paid-205.28M--125.93M113.68M113.68M125.86M142.10M157.93M168.94M162.11M175.26M166.45M185.56M180.12M312.78M220.05M282.45M453.04M
FCF to OCF63.88%66.66%63.91%90.64%40.85%841.13%63.67%62.52%73.80%74.83%53.78%71.23%74.18%87.12%-42.04%87.87%4.65%66.14%44.07%79.02%
Dividend Paid to FCF-336.82%--318.14%-115.15%105.24%101.42%61.92%81.87%80.71%99.03%47.31%47.06%-184.97%19.81%2353.69%47.98%140.31%78.57%

Earnings

Report DateMar 31, 2010Jun 30, 2010Sep 30, 2010Dec 31, 2010Mar 31, 2011Jun 30, 2011Sep 30, 2011Dec 31, 2011Mar 31, 2012Jun 30, 2012Sep 30, 2012Dec 31, 2012Apr 24, 2013Jun 30, 2013Sep 30, 2013Dec 31, 2013Mar 31, 2014Jul 22, 2014Oct 24, 2014Dec 31, 2014Apr 17, 2015Jul 17, 2015Oct 26, 2015Jan 22, 2016Apr 21, 2016Aug 18, 2016Oct 24, 2016Feb 13, 2017Apr 25, 2017Jul 25, 2017Oct 26, 2017Feb 9, 2018Apr 20, 2018Aug 21, 2018Oct 26, 2018Jan 29, 2019Mar 31, 2019Jun 30, 2019Sep 30, 2019Dec 31, 2019Apr 29, 2020Aug 28, 2020Oct 23, 2020Dec 31, 2020Apr 27, 2021Aug 27, 2021Oct 22, 2021Dec 31, 2021Apr 28, 2022Jun 30, 2022Sep 30, 2022Dec 31, 2022Mar 31, 2023Jun 30, 2023Sep 30, 2023Feb 19, 2024May 10, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024May 9, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
EPS Estimate------------0.08-----------------------------------------------------
EPS Actual0.050.110.050.120.050.110.020.140.050.120.040.150.080.130.070.120.090.150.080.120.110.180.070.150.120.180.080.170.130.190.070.180.150.210.110.140.160.220.140.170.090.330.200.150.201.64-0.650.130.160.270.240.210.180.410.130.380.180.430.130.360.140.530.120.400.170.49
Surprise------------0.00%-----------------------------------------------------
Timing------------After-hours----Pre-marketPre-market-Pre-marketPre-marketPre-marketPre-marketPre-marketPre-marketAfter-hoursAfter-hoursPre-market-Pre-marketAfter-hoursPre-marketPre-marketPre-marketPre-market------------Pre-market------After-hoursAfter-hours---After-hours-----

Key Statistics & Ratios

Market Cap11.09B
Enterprise Value9.25B
Trailing P/E16.71
Forward P/E30.40
PEG Ratio0.00
Price / Sales5.00
Price / Book2.19
EPS1.16
Book Value8.99
Revenue (TTM)2.22B
Gross Profit (TTM)1.84B
EBITDA671.73M
Profit Margin29.80%
Operating Margin43.46%
Return on Equity14.26%
Return on Assets4.94%
Shares Outstanding572.12M
Shares Float102.36M
Beta0.14
Dividend Yield3.35%
Dividend Rate0.64
Payout Ratio54.55%

Dividends

20261×
0.41Jun 17, 2026
20253×
0.22Sep 22, 20250.38Jul 10, 20250.22Jan 24, 2025
20241×
0.48Jul 4, 2024
20231×
0.39Jul 20, 2023
20221×
0.59Jul 19, 2022
20211×
0.34Jul 8, 2021
20201×
0.35Jul 17, 2020
20191×
0.31Jul 11, 2019
20181×
0.32Jul 11, 2018
20171×
0.30Jul 17, 2017
20161×
0.32Jul 15, 2016
20151×
0.30Jun 17, 2015
20141×
0.27Jun 26, 2014
20131×
0.24May 31, 2013
20121×
0.22Jun 15, 2012
20111×
0.22May 20, 2011
20101×
0.24Jun 24, 2010

Stock Splits

  • Jul 11, 20191.2983:1